Search
Search Results
##search.searchResults.foundPlural##
-
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1603PDF: 892HTML: 1865Untitled: 193Untitled: 177 -
-
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6785PDF: 3634HTML: 749 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3868Suppl. Files: 1098PDF: 1060Html: 169 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3652PDF: 1425HTML: 178 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5113PDF: 1311HTML: 2736Cover letter: 189 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2148PDF: 1463HTML: 260 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4072PDF: 1574HTML: 924 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2223PDF: 863HTML: 2085 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1700PDF: 830HTML: 142 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2374PDF: 848HTML: 2450 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2551PDF: 857HTML: 17463Fig1 Caligaris: 165Fig.2 Caliga: 197 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2148PDF: 1991HTML: 166 -
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2072PDF: 1662HTML: 363 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1020PDF: 1145Suppl. Files: 568HTML: 78 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3135PDF: 1130HTML: 1476Untitled: 170Untitled: 162Untitled: 164 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2468PDF: 835HTML: 8807Efremov 1: 221Efremov 2: 182 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3497PDF: 1542HTML: 73 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3031PDF: 869HTML: 7158Kost Fig1: 178Kost Fig 2: 175Kost Fig3: 171Kost Fig 4: 185Kost Fig5: 183Kost fig 6: 169 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2617PDF: 1071HTML: 109 -
How I treat acute and persistent sickle cell pain
1898PDF: 1110HTML: 477 -
-
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2767PDF: 1111HTML: 11214 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3726PDF: 1464HTML: 478Figures . Eliassian: 216 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3513PDF: 2391HTML: 1449 -
IMMUNOLOGY OF TUBERCULOSIS
5231PDF: 1995HTML: 7286Untitled: 195 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3165PDF: 1419HTML: 5839Fig1-Ag-Pil: 220Ag-Pil Fig.2: 223 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3717PDF: 1552HTML: 8022Randi Fig: 175 -
SICKLE CELL ANAEMIA AND MALARIA
11374PDF: 6958HTML: 23820Figures Malaria and SCK: 203 -
-
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2558PDF: 797HTML: 5203 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2199PDF: 954HTML: 1885 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2265PDF: 1318HTML: 17072Bassan Fig.1: 140Bassan Fig.2: 151Bassan Fig.4: 138Fig.3: 179







